1887

Chapter 41 : , and

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

, and , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap41-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap41-2.gif

Abstract:

This chapter talks about various environmental organisms that include , , , , , , , , and spp. in water, soil, the rhizosphere, and in and on plants including fruits and vegetables. Members of these genera are widely recognized as phytopathogens. The species discussed in the chapter grow well on standard laboratory media such as 5% sheep blood and chocolate agars. Genotyping strategy provides robust, reproducible, and portable results and is quickly becoming the preferred method for investigating bacterial epidemiology, evolution, and population structure. Repetitive-sequence PCR using a BOX A1R primer and multilocus variable-number tandem repeat analysis have been developed for to exclude a clonal outbreak. Of the organisms discussed in the chapter, is the only one for which serologic tests have been used clinically to diagnose the infection. The indirect hemagglutination assay, although not available commercially, is the most widely used test. It is performed by using a prepared antigen from strains of sensitized to sheep cells and includes unsensitized cells as a control. This assay can be adapted to a microtiter plate test system. MIC broth microdilution and the Etest are the preferred methodologies for susceptibility testing. For multiresistant strains, consideration could be given to testing for synergy with double or triple combinations of antimicrobial agents in reference laboratories. It is important to note, however, that neither checkerboard MIC broth microdilution testing nor multiple combination bactericidal antibiotic testing is standardized at present.

Citation: LiPuma J, Currie B, Peacock S, Vandamme P. 2011. , and , p 692-713. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch41

Key Concept Ranking

Gram-Negative Bacilli
0.535887
Antimicrobial Susceptibility Testing
0.4468415
Restriction Fragment Length Polymorphism
0.4396897
Type III Secretion System
0.4255062
Infectious Diseases
0.41578114
0.535887
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

(a) Gram stain of in a blood culture; (b) Gram stain of from a colony on blood agar.

Citation: LiPuma J, Currie B, Peacock S, Vandamme P. 2011. , and , p 692-713. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch41
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(a) B. pseudomallei colonies on MacConkey agar; (b) B. pseudomallei colonies on blood agar; (c) B. pseudomallei colonies on Ashdown medium agar.

Citation: LiPuma J, Currie B, Peacock S, Vandamme P. 2011. , and , p 692-713. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch41
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap41
1. Aaron, S. D.,, W. Ferris,, D. A. Henry,, D. P. Speert,, and N. E. Macdonald. 2000. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am. J. Respir. Crit. Care Med. 161:12061212.
2. Agger, W. A.,, T. H. Cogbill,, H. Busch, Jr.,, J. Landercasper,, and S. M. Callister. 1986. Wounds caused by corn-harvesting machines: an unusual source of infection due to Gram-negative bacilli. Rev. Infect. Dis. 8:927931.
3. Agodi, A.,, M. Barchitta,, V. Giannino,, A. Collura,, T. Pensabene,, M. L. Garlaschi,, C. Pasquarella,, F. Luzzaro,, F. Sinatra,, E. Mahenthiralingam,, and S. Stefani. 2002. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. J. Hosp. Infect. 50:188195.
4. Alexander, B. D.,, E. W. Petzold,, L. B. Reller,, S. M. Palmer,, R. D. Davis,, C. W. Woods,, and J. J. LiPuma. 2008. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am. J. Transplant. 8:10251030.
5. Alfieri, N.,, K. Ramotar,, P. Armstrong,, M. E. Spornitz,, G. Ross,, J. Winnick,, and D. R. Cook. 1999. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing. Infect. Control Hosp. Epidemiol. 20:553556.
6. Amornchai, P.,, W. Chierakul,, V. Wuthiekanun,, Y. Mahakhunkijcharoen,, R. Phetsouvanh,, B. J. Currie,, P. N. Newton,, N. van Vinh Chau,, S. Wongratanacheewin,, N. P. Day,, and S. J. Peacock. 2007. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J. Clin. Microbiol. 45:37743776.
7. Arda, B.,, S. Aydemir,, T. Yamazhan,, A. Hassan,, A. Tunger,, and D. Serter. 2003. Comamonas testosteroni meningitis in a patient with recurrent cholesteatoma. APMIS 111:474476.
8. Aris, R. M.,, J. C. Routh,, J. J. LiPuma,, D. G. Heath,, and P. H. Gilligan. 2001. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am. J. Respir. Crit. Care Med. 164:21022106.
9. Arpi, M.,, M. A. Victor,, I. Mortensen,, A. Gottschau,, and B. Bruun. 1996. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods. APMIS 104:108114.
10. Ashdown, L. R. 1987. Indirect haemagglutination test for melioidosis. Med. J. Aust. 147:364365.
11. Ashdown, L. R. 1992. Melioidosis and safety in the clinical laboratory. J. Hosp. Infect. 21:301306.
12. Athan, E.,, A. M. Allworth,, C. Engler,, I. Bastian,, and A. C. Cheng. 2005. Melioidosis in tsunami survivors. Emerg. Infect. Dis. 11:16381639.
13. Balandreau, J.,, V. Viallard,, B. Cournoyer,, T. Coenye,, S. Laevens,, and P. Vandamme. 2001. Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl. Environ. Microbiol. 67:982985.
14. Baldwin, A.,, E. Mahenthiralingam,, K. M. Thickett,, D. Honeybourne,, M. C. Maiden,, J. R. Govan,, D. P. Speert,, J. J. LiPuma,, P. Vandamme,, and C. G. Dowson. 2005. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J. Clin. Microbiol. 43:46654673.
15. Barbaro, D. J.,, P. A. Mackowiak,, S. S. Barth,, and P. M. Southern, Jr. 1987. Pseudomonas testosteroni infections: eighteen recent cases and a review of the literature. Rev. Infect. Dis. 9:124129.
16. Barker, P. M.,, R. E. Wood,, and P. H. Gilligan. 1997. Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr. Pulmonol. 23:123125.
17. Bauernfeind, A.,, I. Schneider,, R. Jungwirth,, and C. Roller. 1999. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J. Clin. Microbiol. 37:13351339.
18. Berriatua, E.,, I. Ziluaga,, C. Miguel-Virto,, P. Uribarren,, R. Juste,, S. Laevens,, P. Vandamme,, and J. R. Govan. 2001. Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J. Clin. Microbiol. 39:990994.
19. Blackburn, L.,, K. Brownlee,, S. Conway,, and M. Denton. 2004. Cepacia syndrome’ with Burkholderia multivorans, 9 years after initial colonization. J. Cyst. Fibros. 3:133134.
20. Boutros, N.,, N. Gonullu,, A. Casetta,, M. Guibert,, D. Ingrand,, and L. Lebrun. 2002. Ralstonia pickettii traced in blood culture bottles. J. Clin. Microbiol. 40:26662667.
21. Brett, P. J.,, D. DeShazer,, and D. E. Woods. 1998. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48(Pt. 1):317320.
22. Brisse, S.,, S. Stefani,, J. Verhoef,, A. Van Belkum,, P. Vandamme,, and W. Goessens. 2002. Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J. Clin. Microbiol. 40:17431748.
23. Brisse, S.,, C. M. Verduin,, D. Milatovic,, A. Fluit,, J. Verhoef,, S. Laevens,, P. Vandamme,, B. Tummler,, H. A. Verbrugh,, and A. van Belkum. 2000. Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. J. Clin. Microbiol. 38:18761884.
24. Burbage, D. A.,, M. Sasser,, and R. D. Lumsden. 1982. A medium selective for Pseudomonas cepacia. Phytopathology 72:706.
25. Burdge, D. R.,, M. A. Noble,, M. E. Campbell,, V. L. Krell,, and D. P. Speert. 1995. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin. Infect. Dis. 20:445448.
26. Burns, J. L.,, J. Emerson,, J. R. Stapp,, D. L. Yim,, J. Krzewinski,, L. Louden,, B. W. Ramsey,, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27:158163.
27.Centers for Disease Control and Prevention. 2000. Laboratory-acquired human glanders—Maryland, May 2000. MMWR Morb. Mortal. Wkly. Rep. 49:532535.
28. Chantratita, N.,, E. Meumann,, A. Thanwisai,, D. Limmathurotsakul,, V. Wuthiekanun,, S. Wannapasni,, S. Tumapa,, N. P. Day,, and S. J. Peacock. 2008. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J. Clin. Microbiol. 46:568573.
29. Chantratita, N.,, V. Wuthiekanun,, D. Limmathurotsakul,, A. Thanwisai,, W. Chantratita,, N. P. Day,, and S. J. Peacock. 2007. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am. J. Trop. Med. Hyg. 77:814817.
30. Chantratita, N.,, V. Wuthiekanun,, D. Limmathurotsakul,, M. Vesaratchavest,, A. Thanwisai,, P. Amornchai,, S. Tumapa,, E. J. Feil,, N. P. Day,, and S. J. Peacock. 2008. Genetic diversity and microevolution of Burkholderia pseudomallei in the environment. PLoS Negl. Trop. Dis. 2:e182.
31. Chaowagul, W.,, W. Chierakul,, A. J. Simpson,, J. M. Short,, K. Stepniewska,, B. Maharjan,, A. Rajchanuvong,, D. Busarawong,, D. Limmathurotsakul,, A. C. Cheng,, V. Wuthiekanun,, P. N. Newton,, N. J. White,, N. P. Day,, and S. J. Peacock. 2005. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprimsulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob. Agents Chemother. 49:40204025.
32. Chaowagul, W.,, Y. Suputtamongkul,, M. D. Smith,, and N. J. White. 1997. Oral fluoroquinolones for maintenance treatment of melioidosis. Trans. R. Soc. Trop. Med. Hyg. 91:599601.
33. Chaowagul, W.,, N. J. White,, D. A. Dance,, Y. Wattanagoon,, P. Naigowit,, T. M. Davis,, S. Looareesuwan,, and N. Pitakwatchara. 1989. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J. Infect. Dis. 159:890899.
34. Chen, J. S.,, K. A. Witzmann,, T. Spilker,, R. J. Fink,, and J. J. LiPuma. 2001. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139:643649.
35. Chen, W. M.,, S. Laevens,, T. M. Lee,, T. Coenye,, P. De Vos,, M. Mergeay,, and P. Vandamme. 2001. Ralstonia taiwanensis sp. nov., isolated from root nodules of Mimosa species and sputum of a cystic fibrosis patient. Int. J. Syst. Evol. Microbiol. 51:17291735.
36. Cheng, A. C.,, W. Chierakul,, W. Chaowagul,, P. Chetchotisakd,, D. Limmathurotsakul,, D. A. Dance,, S. J. Peacock,, and B. J. Currie. 2008. Consensus guidelines for dosing of amoxicillinclavulanate in melioidosis. Am. J. Trop. Med. Hyg. 78:208209.
37. Cheng, A. C.,, and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383416.
38. Cheng, A. C.,, D. A. Fisher,, N. M. Anstey,, D. P. Stephens,, S. P. Jacups,, and B. J. Currie. 2004. Outcomes of patients with melioidosis treated with meropenem. Antimicrob. Agents Chemother. 48:17631765.
39. Cheng, A. C.,, D. Godoy,, M. Mayo,, D. Gal,, B. G. Spratt,, and B. J. Currie. 2004. Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J. Clin. Microbiol. 42:54775483.
40. Cheng, A. C.,, D. Limmathurotsakul,, W. Chierakul,, N. Getchalarat,, V. Wuthiekanun,, D. P. Stephens,, N. P. Day,, N. J. White,, W. Chaowagul,, B. J. Currie,, and S. J. Peacock. 2007. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin. Infect. Dis. 45:308314.
41. Cheng, A. C.,, M. O’Brien,, K. Freeman,, G. Lum,, and B. J. Currie. 2006. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am. J. Trop. Med. Hyg. 74:330334.
42. Cheng, A. C.,, S. J. Peacock,, D. Limmathurotsakul,, G. Wongsuvan,, W. Chierakul,, P. Amornchai,, N. Getchalarat,, W. Chaowagul,, N. J. White,, N. P. Day,, and V. Wuthiekanun. 2006. Prospective evaluation of a rapid immunochromogenic cassette test for the diagnosis of melioidosis in northeast Thailand. Trans. R. Soc. Trop. Med. Hyg. 100:6467.
43. Cheng, A. C.,, D. P. Stephens,, and B. J. Currie. 2007. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. Cochrane Database Syst. Rev., Issue 2, Art. no. CD004400. doi: 10.1002/14651858.CD004400.pub3.ed.
44. Cheng, A. C.,, V. Wuthiekanun,, D. Limmathurosakul,, G. Wongsuvan,, N. P. Day,, and S. J. Peacock. 2006. Role of selective and nonselective media for isolation of Burkholderia pseudomallei from throat swabs of patients with melioidosis. J. Clin. Microbiol. 44:2316.
45. Chetoui, H.,, P. Melin,, M. J. Struelens,, E. Delhalle,, M. M. Nigo,, R. De Ryck,, and P. De Mol. 1997. Comparison of biotyping, ribotyping, and pulsed-field gel electrophoresis for investigation of a common-source outbreak of Burkholderia pickettii bacteremia. J. Clin. Microbiol. 35:13981403.
46. Chi, C. Y.,, C. P. Fung,, W. W. Wong,, and C. Y. Liu. 2004. Brevundimonas bacteremia: two case reports and literature review. Scand. J. Infect. Dis. 36:5961.
47. Chierakul, W.,, S. Anunnatsiri,, J. M. Short,, B. Maharjan,, P. Mootsikapun,, A. J. Simpson,, D. Limmathurotsakul,, A. C. Cheng,, K. Stepniewska,, P. N. Newton,, W. Chaowagul,, N. J. White,, S. J. Peacock,, N. P. Day,, and P. Chetchotisakd. 2005. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprimsulfamethoxazole for the treatment of severe melioidosis. Clin. Infect. Dis. 41:11051113.
48. Chierakul, W.,, W. Winothai,, C. Wattanawaitunechai,, V. Wuthiekanun,, T. Rugtaengan,, J. Rattanalertnavee,, P. Jitpratoom,, W. Chaowagul,, P. Singhasivanon,, N. J. White,, N. P. Day,, and S. J. Peacock. 2005. Melioidosis in 6 tsunami survivors in southern Thailand. Clin. Infect. Dis. 41:982990.
49. Christenson, J. C.,, D. F. Welch,, G. Mukwaya,, M. J. Muszynski,, R. E. Weaver,, and D. J. Brenner. 1989. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J. Clin. Microbiol. 27:270273.
50.Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informal Supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
51. Clode, F. E.,, L. A. Metherell,, and T. L. Pitt. 1999. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 160:374375.
52. Coenye, T.,, E. Falsen,, B. Hoste,, M. Ohlen,, J. Goris,, J. R. Govan,, M. Gillis,, and P. Vandamme. 2000. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int. 2. J. Syst. Evol. Microbiol. 50(Pt. 2):887899.
53. Coenye, T.,, E. Falsen,, M. Vancanneyt,, B. Hoste,, J. R. Govan,, K. Kersters,, and P. Vandamme. 1999. Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int. J. Syst. Bacteriol. 49:405413.
54. Coenye, T.,, J. Goris,, P. De Vos,, P. Vandamme,, and J. J. LiPuma. 2003. Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov. Int. J. Syst. Evol. Microbiol. 53:10751080.
55. Coenye, T.,, J. Goris,, T. Spilker,, P. Vandamme,, and J. J. LiPuma. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J. Clin. Microbiol. 40:20622069.
56. Coenye, T.,, B. Holmes,, K. Kersters,, J. R. W. Govan,, and P. Vandamme. 1999. Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al. 1995 and Burkholderia vandii Urakami et al. 1994 are junior synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al. 1994, respectively. Int. J. Syst. Bacteriol. 49:3742.
57. Coenye, T.,, S. Laevens,, A. Willems,, M. Ohlen,, W. Hannant,, J. R. W. Govan,, M. Gillis,, E. Falsen,, and P. Vandamme. 2001. Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. Int. J. Syst. Evol. Microbiol. 51:10991107.
58. Coenye, T.,, and J. J. LiPuma. 2002. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 149:7788.
59. Coenye, T.,, and J. J. LiPuma. 2002. Use of the gyrB gene for the identification of Pandoraea species. FEMS Microbiol. Lett. 208:1519.
60. Coenye, T.,, L. Liu,, P. Vandamme,, and J. J. LiPuma. 2001. Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J. Clin. Microbiol. 39:44524455.
61. Coenye, T.,, E. Mahenthiralingam,, D. Henry,, J. J. LiPuma,, S. Laevens,, M. Gillis,, D. P. Speert,, and P. Vandamme. 2001. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int. J. Syst. Evol. Microbiol. 51:14811490.
62. Coenye, T.,, L. M. Schouls,, J. R. Govan,, K. Kersters,, and P. Vandamme. 1999. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int. J. Syst. Bacteriol. 49(Pt 4):16571666.
63. Coenye, T.,, T. Spilker,, A. Martin,, and J. J. LiPuma. 2002. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J. Clin. Microbiol. 40:33003307.
64. Coenye, T.,, T. Spilker,, R. Reik,, P. Vandamme,, and J. J. LiPuma. 2005. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J. Clin. Microbiol. 43:34633466.
65. Coenye, T.,, T. Spilker,, A. Van Schoor,, J. J. LiPuma,, and P. Vandamme. 2004. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax 59:952954.
66. Coenye, T.,, P. Vandamme,, J. R. Govan,, and J. J. LiPuma. 2001. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 39:34273436.
67. Coenye, T.,, P. Vandamme,, and J. J. LiPuma. 2002. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg. Infect. Dis. 8:692696.
68. Coenye, T.,, P. Vandamme,, and J. J. LiPuma. 2003. Ralstonia respiraculi sp. nov., isolated from the respiratory tract of cystic fibrosis patients. Int. J. Syst. Evol. Microbiol. 53:13391342.
69. Coenye, T.,, E. Vanlaere,, E. Falsen,, and P. Vandamme. 2004. Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993. Int. J. Syst. Evol. Microbiol. 54:12351237.
70. Cooper, G. R.,, E. D. Staples,, K. A. Iczkowski,, and C. J. Clancy. 2005. Comamonas (Pseudomonas) testosteroni endocarditis. Cardiovasc. Pathol. 14:145149.
71. Corey, M.,, and V. Farewell. 1996. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am. J. Epidemiol. 143:10071017.
72. Craven, D. E.,, B. Moody,, M. G. Connolly,, N. R. Kollisch,, K. D. Stottmeier,, and W. R. McCabe. 1981. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N. Engl. J. Med. 305:621623.
73. Currie, B. J.,, D. A. Dance,, and A. C. Cheng. 2008. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S1S4.
74. Currie, B. J.,, D. A. Fisher,, D. M. Howard,, and J. N. Burrow. 2000. Neurological melioidosis. Acta Trop. 74:145151.
75. Currie, B. J.,, D. A. Fisher,, D. M. Howard,, J. N. Burrow,, D. Lo,, S. Selva-Nayagam,, N. M. Anstey,, S. E. Huffam,, P. L. Snelling,, P. J. Marks,, D. P. Stephens,, G. D. Lum,, S. P. Jacups,, and V. L. Krause. 2000. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 31:981986.
76. Currie, B. J.,, D. Gal,, M. Mayo,, L. Ward,, D. Godoy,, B. G. Spratt,, and J. J. LiPuma. 2007. Using BOX-PCR to exclude a clonal outbreak of melioidosis, p. 68. BMC Infect. Dis. 7:68.
77. Currie, B. J.,, A. Haslem,, T. Pearson,, H. Hornstra,, B. Leadem,, M. Mayo,, D. Gal,, L. Ward,, D. Godoy,, B. G. Spratt,, and P. Keim. 2009.Identification of melioidosis outbreak by multilocus variable number tandem repeat analysis. Emerg. Infect. Dis. 15:169174.
78. Currie, B. J.,, and S. P. Jacups. 2003. Intensity of rainfall and severity of melioidosis, Australia. Emerg. Infect. Dis. 9:15381542.
79. Currie, B. J.,, S. P. Jacups,, A. C. Cheng,, D. A. Fisher,, N. M. Anstey,, S. E. Huffam,, and V. L. Krause. 2004. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop. Med. Int. Health 9:11671174.
80.Cystic Fibrosis Foundation. 2008. Patient Registry 2008. Annual Data Report to the Center Directors. Cystic Fibrosis Foundation, Bethesda, MD.
81. Dance, D. A.,, M. D. Smith,, H. M. Aucken,, and T. L. Pitt. 1999. Imported melioidosis in England and Wales. Lancet 353:208.
82. Dance, D. A.,, V. Wuthiekanun,, P. Naigowit,, and N. J. White. 1989. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J. Clin. Pathol. 42:645648.
83. Daneshvar, M. I.,, D. G. Hollis,, A. G. Steigerwalt,, A. M. Whitney,, L. Spangler,, M. P. Douglas,, J. G. Jordan,, J. P. MacGregor,, B. C. Hill,, F. C. Tenover,, D. J. Brenner,, and R. S. Weyant. 2001. Assignment of CDC weak oxidizergroup (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J. Clin. Microbiol. 39:18191826.
84. da Silva Filho, L. V. F.,, A. F. Tateno,, L. de F. Velloso,, J. E. Levi,, S. Fernandes,, C. N. O. Bento,, J. C. Rodrigues,, and S. R. T. S. Ramos. 2004. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR. Pediatr. Pulmonol. 37:537547.
85. De Baere, T.,, S. Steyaert,, G. Wauters,, P. Des Vos,, J. Goris,, T. Coenye,, T. Suyama,, G. Verschraegen,, and M. Vaneechoutte. 2001. Classification of Ralstonia pickettii biovar 3/‘thomasii’ strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int. J. Syst. Evol. Microbiol. 51:547558.
86. De Boeck, K.,, A. Malfroot,, L. Van Schil,, P. Lebecque,, C. Knoop,, J. R. Govan,, C. Doherty,, S. Laevens,, and P. Vandamme. 2004. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients. Eur. Respir. J. 23:851856.
87. Deepak, R. N.,, B. Crawley,, and E. Phang. 2008. Burkholderia pseudomallei identification: a comparison between the API 20NE and VITEK2GN systems. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S42S44.
88. Demko, C. A.,, R. C. Stern,, and C. F. Doershuk. 1998. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr. Pulmonol. 25:304308.
89. Denton, M.,, M. J. Hall,, N. J. Todd,, K. G. Kerr,, and J. M. Littlewood. 2000. Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium. Clin. Microbiol. Infect. 6:397398.
90. Denton, M.,, and K. G. Kerr. 1998. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11:5780.
91. Denton, M.,, N. J. Todd,, K. G. Kerr,, P. M. Hawkey,, and J. M. Littlewood. 1998. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36:19531958.
92. Desakorn, V.,, M. D. Smith,, V. Wuthiekanun,, D. A. Dance,, H. Aucken,, P. Suntharasamai,, A. Rajchanuwong,, and N. J. White. 1994. Detection of Pseudomonas pseudomallei antigen in urine for the diagnosis of melioidosis. Am. J. Trop. Med. Hyg. 51:627633.
93. De Soyza, A.,, A. McDowell,, L. Archer,, J. H. Dark,, S. J. Elborn,, E. Mahenthiralingam,, K. Gould,, and P. A. Corris. 2001. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358:17801781.
94. Drancourt, M.,, C. Bollet,, and D. Raoult. 1997. Stenotrophomonas africana sp. nov., an opportunistic human pathogen in Africa. Int. J. Syst. Bacteriol. 47:160163.
95. Ender, P. T.,, D. P. Dooley,, and R. H. Moore. 1996. Vascular catheter-related Comamonas acidovorans bacteremia managed with preservation of the catheter. Pediatr. Infect. Dis. J. 15:918920.
96. Fernandez, C.,, I. Wilhelmi,, E. Andradas,, C. Gaspar,, J. Gomez,, J. Romero,, J. A. Mariano,, O. Corral,, M. Rubio,, J. Elviro,, and J. Fereres. 1996. Nosocomial outbreak of Burkholderia pickettii infection due to a manufactured intravenous product used in three hospitals. Clin. Infect. Dis. 22:10921095.
97. Feterl, M.,, B. Govan,, C. Engler,, R. Norton,, and N. Ketheesan. 2006. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model. Int. J. Antimicrob. Agents 28:460464.
98. Fiore, A.,, S. Laevens,, A. Bevivino,, C. Dalmastri,, S. Tabacchioni,, P. Vandamme,, and L. Chiarini. 2001. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy. Environ. Microbiol. 3:137143.
99. Fujita, J.,, I. Yamadori,, G. Xu,, S. Hojo,, K. Negayama,, H. Miyawaki,, Y. Yamaji,, and J. Takahara. 1996. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir. Med. 90:3538.
100. Gardan, L.,, D. E. Stead,, C. Dauga,, and M. Gillis. 2003. Acidovorax valerianellae sp. nov., a novel pathogen of lamb’s lettuce [Valerianella locusta (L.) Laterr.]. Int. J. Syst. Evol. Microbiol. 53:795800.
101. Garrison, M. W.,, D. E. Anderson,, D. M. Campbell,, K. C. Carroll,, C. L. Malone,, J. D. Anderson,, R. J. Hollis,, and M. A. Pfaller. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40:28592864.
102. Gee, J. E.,, M. B. Glass,, R. T. Novak,, D. Gal,, M. J. Mayo,, A. G. Steigerwalt,, P. P. Wilkins,, and B. J. Currie. 2008. Recovery of a Burkholderia thailandensis-like isolate from an Australian water source. BMC Microbiol. 8:54.
103. Gibney, K. B.,, A. C. Cheng,, and B. J. Currie. 2008. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin. Infect. Dis. 47:603609.
104. Gilad, J.,, A. Borer,, N. Peled,, K. Riesenberg,, S. Tager,, A. Appelbaum,, and F. Schlaeffer. 2000. Hospital-acquired Brevundimonas vesicularis septicaemia following open-heart surgery: case report and literature review. Scand. J. Infect. Dis. 32:9091.
105. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:3551.
106. Gilligan, P. H.,, P. A. Gage,, L. M. Bradshaw,, D. V. Schidlow,, and B. T. DeCicco. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 22:58.
107. Giordano, A.,, A. Magni,, M. Trancassini,, P. Varesi,, R. Turner,, and C. Mancini. 2006. Identification of respiratory isolates of Stenotrophomonas maltophilia by commercial biochemical systems and species-specific PCR. J. Microbiol. Methods 64:135138.
108. Glass, M. B.,, and T. Popovic. 2005. Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J. Clin. Microbiol. 43:479483.
109. Godoy, D.,, G. Randle,, A. J. Simpson,, D. M. Aanensen,, T. L. Pitt,, R. Kinoshita,, and B. G. Spratt. 2003. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J. Clin. Microbiol. 41:20682079.
110. Goris, J.,, P. De Vos,, T. Coenye,, B. Hoste,, D. Janssens,, H. Brim,, L. Diels,, M. Mergeay,, K. Kersters,, and P. Vandamme. 2001. Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend. Int. J. Syst. Evol. Microbiol. 51:17731782.
111. Goss, C. H.,, K. Otto,, M. L. Aitken,, and G. D. Rubenfeld. 2002. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 166:356361.
112. Govan, J. R.,, J. E. Hughes,, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395407.
113. Graff, G. R.,, and J. L. Burns. 2002. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis. Chest 121:17541760.
114. Graves, M.,, T. Robin,, A. M. Chipman,, J. Wong,, S. Khashe,, and J. M. Janda. 1997. Four additional cases of Burkholderia gladioli infection with microbiological correlates and review. Clin. Infect. Dis. 25:838842.
115. Haase, A.,, M. Brennan,, S. Barrett,, Y. Wood,, S. Huffam,, D. O’Brien,, and B. Currie. 1998. Evaluation of PCR for diagnosis of melioidosis. J. Clin. Microbiol. 36:10391041.
116. Hagedorn, C.,, W. D. Gould,, T. R. Bardinelli,, and D. R. Gustavson. 1987. A selective medium for enumeration and recovery of Pseudomonas cepacia biotypes from soil. Appl. Environ. Microbiol. 53:22652268.
117. Han, X. Y.,, and R. A. Andrade. 2005. Brevundimonas diminuta infections and its resistance to fluoroquinolones. J. Antimicrob. Chemother. 55:853859.
118. Hancock, R. E. 1998. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin. Infect. Dis. 27(Suppl. 1):S93S99.
119. Hanes, S. D.,, K. Demirkan,, E. Tolley,, B. A. Boucher,, M. A. Croce,, G. C. Wood,, and T. C. Fabian. 2002. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin. Infect. Dis. 35:228235.
120. Heine, H. S.,, M. J. England,, D. M. Waag,, and W. R. Byrne. 2001. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob. Agents Chemother. 45:21192121.
121. Henry, D.,, M. Campbell,, C. McGimpsey,, A. Clarke,, L. Louden,, J. L. Burns,, M. H. Roe,, P. Vandamme,, and D. Speert. 1999. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 37: 10041007.
122. Henry, D. A.,, M. E. Campbell,, J. J. LiPuma,, and D. P. Speert. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J. Clin. Microbiol. 35:614619.
123. Henry, D. A.,, E. Mahenthiralingam,, P. Vandamme,, T. Coenye,, and D. P. Speert. 2001. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 39:10731078.
124. Heylen, K.,, B. Vanparys,, F. Peirsegaele,, L. Lebbe,, and P. De Vos. 2007. Stenotrophomonas terrae sp. nov. and Stenotrophomonas humi sp. nov., two nitrate-reducing bacteria isolated from soil. Int. J. Syst. Evol. Microbiol. 57:20562061.
125. Hoban, D. J.,, S. K. Bouchillon,, J. L. Johnson,, G. G. Zhanel,, D. L. Butler,, L. A. Miller,, J. A. Poupard, et al. 2001. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Diagn. Microbiol. Infect. Dis. 40:5157.
126. Holt, J.,, N. R. Krieg,, A. Sneath,, T. Staley,, and S. T. Williams. 1994. Bergey’s Manual of Determinative Bacteriology, 9th ed., vol. 1. The Williams and Wilkins Company, Philadelphia, PA.
127. Howard, K.,, and T. J. Inglis. 2003. Novel selective medium for isolation of Burkholderia pseudomallei. J. Clin. Microbiol. 41:33123316.
128. Hugh, R.,, and E. Ryschenkow. 1961. Pseudomonas maltophilia, an Alcaligenes-like species. J. Gen. Microbiol. 26:123132.
129. Hutchinson, G. R.,, S. Parker,, J. A. Pryor,, F. Duncan- Skingle,, P. N. Hoffman,, M. E. Hodson,, M. E. Kaufmann,, and T. L. Pitt. 1996. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistinresistant, gram-negative bacteria in patients with cystic fibrosis. J. Clin. Microbiol. 34:584587.
130. Inglis, T. J.,, M. Aravena-Roman,, S. Ching,, K. Croft,, V. Wuthiekanun,, and B. J. Mee. 2003. Cellular fatty acid profile distinguishes Burkholderia pseudomallei from avirulent Burkholderia thailandensis. J. Clin. Microbiol. 41:48124814.
131. Inglis, T. J.,, D. Chiang,, G. S. Lee,, and L. Chor-Kiang. 1998. Potential misidentification of Burkholderia pseudomallei by API 20NE. Pathology 30:6264.
132. Inglis, T. J.,, A. Merritt,, G. Chidlow,, M. Aravena-Roman,, and G. Harnett. 2005. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 43:22012206.
133. Inglis, T. J.,, L. O’Reilly,, N. Foster,, A. Clair,, and J. Sampson. 2002. Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei. J. Clin. Microbiol. 40:31983203.
134. Isles, A.,, I. Maclusky,, M. Corey,, R. Gold,, C. Prober,, P. Fleming,, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206210.
135. Jenney, A. W.,, G. Lum,, D. A. Fisher,, and B. J. Currie. 2001. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int. J. Antimicrob. Agents 17:109113.
136. Johnson, L. N.,, J. Y. Han,, S. M. Moskowitz,, J. L. Burns,, X. Qin,, and J. A. Englund. 2004. Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness. Pediatr. Infect. Dis. J. 23:881882.
137. Johnson, W. M.,, S. D. Tyler,, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924930.
138. Jones, A. M.,, T. N. Stanbridge,, B. J. Isalska,, M. E. Dodd,, and A. K. Webb. 2001. Burkholderia gladioli: recurrent abscesses in a patient with cystic fibrosis. J. Infect. 42:6971.
139. Jorgensen, I. M.,, H. K. Johansen,, B. Frederiksen,, T. Pressler,, A. Hansen,, P. Vandamme,, N. Hoiby,, and C. Koch. 2003. Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr. Pulmonol. 36:439446.
140. Kaestli, M.,, M. Mayo,, G. Harrington,, L. Ward,, F. Watt,, J. V. Hill,, A. C. Cheng,, and B. J. Currie. 2009. Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl. Trop. Dis. 3:e364.
141. Kanaphun, P.,, N. Thirawattanasuk,, Y. Suputtamongkol,, P. Naigowit,, D. A. Dance,, M. D. Smith,, and N. J. White. 1993. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J. Infect. Dis. 167:230233.
142. Kenny, D. J.,, P. Russell,, D. Rogers,, S. M. Eley,, and R. W. Titball. 1999. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob. Agents Chem. 43:27732775.
143. Kerr, K. G.,, M. Denton,, N. Todd,, C. M. Corps,, P. Kumari,, and P. M. Hawkey. 1996. A new selective differential medium for isolation of Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 15:607610.
144. Kersters, K.,, W. Ludwig,, M. Vancanneyt,, P. De Vos,, M. Gillis,, and K. H. Schleifer. 1996. Recent changes in the classification of the pseudomonads: an overview. Syst. Appl. Microbiol. 19:465477.
145. Khan, S. U.,, S. M. Gordon,, P. C. Stillwell,, T. J. Kirby,, and A. C. Arroliga. 1996. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. Pediatr. Infect. Dis. J. 15:637639.
146. Kiska, D. L.,, A. Kerr,, M. C. Jones,, J. A. Caracciolo,, B. Eskridge,, M. Jordan,, S. Miller,, D. Hughes,, N. King,, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886891.
147. Krzewinski, J. W.,, C. D. Nguyen,, J. M. Foster,, and J. L. Burns. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39:35973602.
148. Kutty, P. K.,, B. Moody,, J. S. Gullion,, M. Zervos,, M. Ajluni,, R. Washburn,, R. Sanderson,, M. A. Kainer,, T. A. Powell,, C. F. Clarke,, R. J. Powell,, N. Pascoe,, A. Shams,, J. J. LiPuma,, B. Jensen,, J. Noble-Wang,, M. J. Arduino,, and L. C. McDonald. 2007. Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest 132:18251831.
149. Ledson, M. J.,, M. J. Gallagher,, M. Jackson,, C. A. Hart,, and M. J. Walshaw. 2002. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 57:142145.
150. Le Moal, G.,, M. Paccalin,, J. P. Breux,, F. Roblot,, P. Roblot,, and B. Becq-Giraudon. 2001. Central venous catheterrelated infection due to Comamonas testosteroni in a woman with breast cancer. Scand. J. Infect. Dis. 33:627628.
151. Lessie, T. G.,, W. Hendrickson,, B. D. Manning,, and R. Devereux. 1996. Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol. Lett. 144:117128.
152. Limmathurotsakul, D.,, W. Chaowagul,, W. Chierakul,, K. Stepniewska,, B. Maharjan,, V. Wuthiekanun,, N. J. White,, N. P. Day,, and S. J. Peacock. 2006. Risk factors for recurrent melioidosis in northeast Thailand. Clin. Infect. Dis. 43:979986.
153. Liou, T. G.,, F. R. Adler,, S. C. FitzSimmons,, B. C. Cahill,, J. R. Hibbs,, and B. C. Marshall. 2001. Predictive 5-year survivorship model of cystic fibrosis. Am. J. Epidemiol. 153:345352.
154. LiPuma, J. 2003. Burkholderia and emerging pathogens in cystic fibrosis. Semin. Respir. Crit. Care Med. 24:681692.
155. LiPuma, J. J. 2001. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl. Infect. Dis. 3:149160.
156. LiPuma, J. J. 1998. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr. Opin. Pulm. Med. 4:337341.
157. LiPuma, J. J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19:473486.
158. LiPuma, J. J.,, S. E. Dasen,, D. W. Nielson,, R. C. Stern,, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:10941096.
159. LiPuma, J. J.,, B. J. Dulaney,, J. D. McMenamin,, P. W. Whitby,, T. L. Stull,, T. Coenye,, and P. Vandamme. 1999. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J. Clin. Microbiol. 37:31673170.
160. LiPuma, J. J.,, J. E. Mortensen,, S. E. Dasen,, T. D. Edlind,, D. V. Schidlow,, J. L. Burns,, and T. L. Stull. 1988. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J. Pediatr. 113:859862.
161. LiPuma, J. J.,, T. Spilker,, T. Coenye,, and C. F. Gonzalez. 2002. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359:20022003.
162. Lowe, P.,, C. Engler,, and R. Norton. 2002. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 40:46254627.
163. Lowe, P.,, H. Haswell,, and K. Lewis. 2006. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN Card for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 44:854856.
164. Lumbiganon, P.,, U. Tattawasatra,, P. Chetchotisakd,, S. Wongratanacheewin,, and B. Thinkhamrop. 2000. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. J. Med. Assoc. Thai. 83:856860.
165. Mahenthiralingam, E.,, J. Bischof,, S. K. Byrne,, C. Radomski,, J. E. Davies,, Y. Av-Gay,, and P. Vandamme. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38:31653173.
166. Mahenthiralingam, E.,, M. E. Campbell,, D. A. Henry,, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:29142920.
167. Mahenthiralingam, E.,, and P. Drevinek,. 2007. Comparative genomics of Burkholderia species, p. 5379. In T. Coenye, and P. Vandamme (ed.), Burkholderia: Molecular Microbiology and Genomics. Horizon Bioscience, Wymondham, United Kingdom.
168. Makkar, N. S.,, and L. E. Casida, Jr. 1987. Cupriavidus necator gen. nov., sp. nov.; a nonobligate bacterial predator of bacteria in soil. Int. J. Syst. Bacteriol. 37:323326.
169. McDowell, A.,, E. Mahenthiralingam,, J. E. Moore,, K. E. A. Dunbar,, A. K. Webb,, M. E. Dodd,, S. L. Martin,, B. C. Millar,, C. J. Scott,, M. Crowe,, and J. S. Elborn. 2001. PCRbased detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J. Clin. Microbiol. 39:42474255.
170. McMenamin, J. D.,, T. M. Zaccone,, T. Coenye,, P. Vandamme,, and J. J. LiPuma. 2000. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 117:16611665.
171. Meumann, E. M.,, R. T. Novak,, D. Gal,, M. E. Kaestli,, M. Mayo,, J. P. Hanson,, E. Spencer,, M. B. Glass,, J. E. Gee,, P. P. Wilkins,, and B. J. Currie. 2006. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J. Clin. Microbiol. 44:30283030.
172. Milatovic, D.,, F. J. Schmitz,, J. Verhoef,, and A. C. Fluit. 2003. Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob. Agents Chemother. 47:400404.
173. Moore, J. E.,, B. McIlhatton,, A. Shaw,, P. G. Murphy,, and J. S. Elborn. 2001. Occurrence of Burkholderia cepacia in foods and waters: clinical implications for patients with cystic fibrosis. J. Food Prot. 64:10761078.
174. Moore, J. E.,, J. Xu,, B. C. Millar,, M. Crowe,, and J. S. Elborn. 2002. Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis. J. Microbiol. Methods 49:183191.
175. Moore, R. A.,, S. Reckseidler-Zenteno,, H. Kim,, W. Nierman,, Y. Yu,, A. Tuanyok,, J. Warawa,, D. DeShazer,, and D. E. Woods. 2004. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect. Immun. 72:41724187.
176. Muder, R. R.,, A. P. Harris,, S. Muller,, M. Edmond,, J. W. Chow,, K. Papadakis,, M. W. Wagener,, G. P. Bodey,, and J. M. Steckelberg. 1996. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin. Infect. Dis. 22:508512.
177. Murray, S.,, J. Charbeneau,, B. C. Marshall,, and J. J. LiPuma. 2008. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am. J. Respir. Crit. Care Med. 178:363371.
178. Ngauy, V.,, Y. Lemeshev,, L. Sadkowski,, and G. Crawford. 2005. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J. Clin. Microbiol. 43:970972.
179. Novak, R. T.,, M. B. Glass,, J. E. Gee,, D. Gal,, M. J. Mayo,, B. J. Currie,, and P. P. Wilkins. 2006. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J. Clin. Microbiol. 44:8590.
180. O’Brien, M.,, K. Freeman,, G. Lum,, A. C. Cheng,, S. P. Jacups,, and B. J. Currie. 2004. Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. J. Clin. Microbiol. 42:22392240.
181. O’Carroll, M. R.,, T. J. Kidd,, C. Coulter,, H. V. Smith,, B. R. Rose,, C. Harbour,, and S. C. Bell. 2003. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax 58:10871091.
182. Oie, S.,, and A. Kamiya. 1996. Microbial contamination of antiseptics and disinfectants. Am. J. Infect. Control 24: 389395.
183. Otag, F.,, G. Ersoz,, M. Salcioglu,, C. Bal,, I. Schneider,, and A. Bauernfeind. 2005. Nosocomial bloodstream infections with Burkholderia stabilis. J. Hosp. Infect. 59:4652.
184. Otto, L. A.,, B. S. Deboo,, E. L. Capers,, and M. J. Pickett. 1978. Pseudomonas vesicularis from cervical specimens. J. Clin. Microbiol. 7:341345.
185. Palleroni, N. J., 1984. Genus I. Pseudomonas Migula 1984 237AL, p. 141199. In J. Holt, and N. R. Krieg (ed.), Bergey’s Manual of Systematic Bacteriology, vol. 1. The Williams and Wilkins Company, Baltimore, MD.
186. Palleroni, N. J.,, and J. F. Bradbury. 1993. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int. J. Syst. Bacteriol. 43:606609.
187. Palleroni, N. J.,, R. Kunisawa,, R. Contopoulou, et al. 1973. Nucleid acid homologies in the genus Pseudomonas. Int. J. Syst. Bacteriol. 23:333.
188. Parke, J. L.,, and D. Gurian-Sherman. 2001. Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu. Rev. Phytopathol. 39:225258.
189. Parry, C. M.,, V. Wuthiekanun,, N. T. Hoa,, T. S. Diep,, L. T. Thao,, P. V. Loc,, B. A. Wills,, J. Wain,, T. T. Hien,, N. J. White,, and J. J. Farrar. 1999. Melioidosis in Southern Vietnam: clinical surveillance and environmental sampling. Clin. Infect. Dis. 29:13231326.
190. Payne, G. W.,, P. Vandamme,, S. H. Morgan,, J. J. LiPuma,, T. Coenye,, A. J. Weightman,, T. H. Jones,, and E. Mahenthiralingam. 2005. Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl. Environ. Microbiol. 71:39173927.
191. Peacock, S. J.,, G. Chieng,, A. C. Cheng,, D. A. Dance,, P. Amornchai,, G. Wongsuvan,, N. Teerawattanasook,, W. Chierakul,, N. P. Day,, and V. Wuthiekanun. 2005. Comparison of Ashdown’s medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J. Clin. Microbiol. 43:53595361.
192. Peacock, S. J.,, H. P. Schweizer,, D. A. Dance,, T. L. Smith,, J. E. Gee,, V. Wuthiekanun,, D. DeShazer,, I. Steinmetz,, P. Tan,, and B. J. Currie. 2008. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg. Infect. Dis. 14:e2.
193. Piliouras, P.,, G. C. Ulett,, C. Ashhurst-Smith,, R. G. Hirst,, and R. E. Norton. 2002. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Int. J. Antimicrob. Agents 19:427429.
194. Pitkin, D. H.,, W. Sheikh,, and H. L. Nadler. 1997. Comparative in vitro activity of meropenem versus other extended- spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers. Clin. Infect. Dis. 24(Suppl. 2):S238S248.
195. Pitt, T. L.,, M. E. Kaufmann,, P. S. Patel,, L. C. Benge,, S. Gaskin,, and D. M. Livermore. 1996. Type characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44:203210.
196. Poole, K.,, and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:5971.
197. Ramette, A.,, J. J. LiPuma,, and J. M. Tiedje. 2005. Species abundance and diversity of Burkholderia cepacia complex in the environment. Appl. Environ. Microbiol. 71:11931201.
198. Razvi, S.,, L. Quittell,, A. Sewall,, H. Quinton,, B. Marshall,, and L. Saiman. 2009. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995-2005. Chest 136:15541560.
199. Reboli, A. C.,, R. Koshinski,, K. Arias,, K. Marks-Austin,, D. Stieritz,, and T. L. Stull. 1996. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect. Control Hosp. Epidemiol. 17:741743.
200. Reik, R.,, T. Spilker,, and J. J. LiPuma. 2005. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J. Clin. Microbiol. 43:29262928.
201. Riley, P. S.,, and R. E. Weaver. 1975. Recognition of Pseudomonas pickettii in the clinical laboratory: biochemical characterization of 62 strains. J. Clin. Microbiol. 1:6164.
202. Ross, J. P.,, S. M. Holland,, V. J. Gill,, E. S. DeCarlo,, and J. I. Gallin. 1995. Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin. Infect. Dis. 21:12911293.
203. Sajjan, U. S.,, L. Sun,, R. Goldstein,, and J. F. Forstner. 1995. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177:10301038.
204. San Gabriel, P.,, J. Zhou,, S. Tabibi,, Y. Chen,, M. Trauzzi,, and L. Saiman. 2004. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 48:168171.
205. Sattler, C. A.,, E. O. Mason, Jr.,, and S. L. Kaplan. 2000. Nonrespiratory Stenotrophomonas maltophilia infection at a children’s hospital. Clin. Infect. Dis. 31:13211330.
206. Segers, P.,, M. Vancanneyt,, B. Pot,, U.